Literature DB >> 31948882

Chronic cerebral hypoperfusion: An undefined, relevant entity.

Antonio Ciacciarelli1, Giuliano Sette2, Franco Giubilei2, Francesco Orzi2.   

Abstract

Despite the large body of data available, chronic cerebral hypoperfusion lacks an operative definition. In a tautological way, the term hypoperfusion is being referred to conditions of "inadequate blood flow", "defects of perfusion" or "dysfunction of autoregulation". The chronicity refers to sustained conditions or wavering states characterized by repeated phases of inefficient functional hyperemia. The phenomenon may affect the whole brain or defined areas. A few defined clinical disorders, including heart failure, hypotension, atherosclerosis of large or small vessels and carotid stenosis are thought to cause progressive brain disorders due to chronic hypoperfusion. The clinical relevance manifests mostly as neurocognitive disorders associated with neuroimaging changes.The available data support a conceptual framework that considerschronic cerebral hypoperfusiona likely, relevant pathogenic mechanism for the neurodegeneration-like progression of the neurocognitive disorders. The relationship between neuropathology, cerebral perfusion, and symptoms progression is, however, elusive for several aspects. Typical microangiopathy findings, such as MRI white matter hyperintensities, may appear in individuals without any cerebrovascular risk or vascular lesions. Pathology features of the MRI changes, such as demyelination and gliosis, may result from dysfunction of the neuro-vascular unit not directly associated withvascular mechanisms. In this review, we aim to overview the most common clinical conditions thought to reflect chronic hypoperfusion.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Carotid stenosis; Chronic cerebral hypoperfusion; Heart failure; Hypotension; Neurocognitive disorders

Year:  2020        PMID: 31948882     DOI: 10.1016/j.jocn.2020.01.026

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  11 in total

1.  The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [18F]FMISO and [64Cu]CuATSM.

Authors:  Philip V Little; Fabian Arnberg; Emma Jussing; Li Lu; Andreas Ingemann Jensen; Nicholas Mitsios; Jan Mulder; Thuy A Tran; Staffan Holmin
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

2.  Neuroprotective Effects of Theobromine in permanent bilateral common carotid artery occlusion rat model of cerebral hypoperfusion.

Authors:  Javeed Ahmad Bhat; Manish Kumar
Journal:  Metab Brain Dis       Date:  2022-05-19       Impact factor: 3.655

3.  Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Suzanne D Vernon; Sherlyn Funk; Lucinda Bateman; Gregory J Stoddard; Sarah Hammer; Karen Sullivan; Jennifer Bell; Saeed Abbaszadeh; W Ian Lipkin; Anthony L Komaroff
Journal:  Front Med (Lausanne)       Date:  2022-06-23

Review 4.  Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.

Authors:  WenQing Xu; Qingke Bai; Qiang Dong; Min Guo; Mei Cui
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

Review 5.  An Overview on the Differential Interplay Among Neurons-Astrocytes-Microglia in CA1 and CA3 Hippocampus in Hypoxia/Ischemia.

Authors:  Daniele Lana; Filippo Ugolini; Maria G Giovannini
Journal:  Front Cell Neurosci       Date:  2020-11-11       Impact factor: 5.505

Review 6.  The role of inflammasomes in vascular cognitive impairment.

Authors:  Luting Poh; Wei Liang Sim; Dong-Gyu Jo; Quynh Nhu Dinh; Grant R Drummond; Christopher G Sobey; Christopher Li-Hsian Chen; Mitchell K P Lai; David Y Fann; Thiruma V Arumugam
Journal:  Mol Neurodegener       Date:  2022-01-09       Impact factor: 14.195

Review 7.  Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models.

Authors:  Jie Li; Haitao Xiang; Chao Huang; Jiashu Lu
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

8.  A Pilot Study of Radiomic Based on Routine CT Reflecting Difference of Cerebral Hemispheric Perfusion.

Authors:  Qingguo Ren; Panpan An; Ke Jin; Xiaona Xia; Zhaodi Huang; Jingxu Xu; Chencui Huang; Qingjun Jiang; Xiangshui Meng
Journal:  Front Neurosci       Date:  2022-03-31       Impact factor: 4.677

9.  Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure.

Authors:  Jan Traub; Markus Otto; Roxane Sell; György A Homola; Petra Steinacker; Patrick Oeckl; Caroline Morbach; Stefan Frantz; Mirko Pham; Stefan Störk; Guido Stoll; Anna Frey
Journal:  ESC Heart Fail       Date:  2022-05-25

Review 10.  Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.